Company intelligence / Profile preview

Yves Grumser Consulting

Lausanne, Vaud, Switzerlandch.linkedin.com ↗

Ownership: Private
Development stage: Other

Overview

Yves Grumser Consulting is an active Swiss-based healthcare/life science consultancy led by Dr. Yves Grumser, who serves as Senior Drug Development and Drug Safety Executive as well as EU Qualified Person for Pharmacovigilance (QPPV). The firm specializes in providing expert advice on drug development processes, regulatory compliance, and pharmacovigilance but does not itself develop drugs or maintain a therapeutic pipeline[1]. There are no indications that it has been acquired or that it operates subsidiaries. Its primary location is Lausanne, Switzerland[1].

Industry: Consulting

Beyond the preview

Go deeper on Yves Grumser Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yves Grumser Consulting.

Explore the full profile